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Background. To perform a radiomics analysis in local recurrence (LR) surveillance of limb soft tissue sarcoma (STS) 
Patients and methods. This is a sub-study of a prospective multicenter study with Institutional Review Board ap-
proval supported by ESSR (European Society of Musculoskeletal Radiology). radiomics analysis was done on fast spin 
echo axial T1w, T2w fat saturated and post-contrast T1w (T1wGd) 1.5T MRI images of consecutively recruited patients 
between March 2016 and September 2018. 
Results. N = 11 adult patients (6 men and 5 women; mean age 57.8 ± 17.8) underwent MRI to exclude STS LR: a 
total of 33 follow-up events were evaluated. A total of 198 data-sets per patients of both pathological and normal 
tissue were analyzed. Four radiomics features were significantly correlated to tumor size (p < 0.02) and four radiomics 
features were correlated with grading (p < 0.05). ROC analysis showed an AUC between 0.71 (95%CI: 0.55–0.87) for 
T1w and 0.96 (95%CI: 0.87–1.00) for post-contrast T1w.
Conclusions. radiomics features allow to differentiate normal tissue from pathological tissue in MRI surveillance of 
local recurrence of STS. radiomics in STS evaluation is useful not only for detection purposes but also for lesion char-
acterization.
Key words: sarcoma; recurrence; magnetic resonance imaging; ROC curve 
Introduction
radiomics is an advanced quantitative image fea-
tures analysis defined as the conversion of clinical 
images to higher dimensional data and the subse-
quent mining of these data for improved decision 
support in research and clinical practice.1 The ma-
jority of clinically available medical images can po-
tentially be evaluated with radiomics analysis. In 
this perspective, images of computed tomography, 
Magnetic Resonance Imaging (MRI), ultrasound, 
mammography or digital breast tomosynthesis 
and Fluorodesoxyglucose Positron-emission to-
mography-computed tomography (FDG PET/CT) 
include more data than what is visible on human 
eyes.1-3 Indeed, mathematical algorithms of radi-
omics examine hundreds of quantitative images 
considering medical images as data sources. The 
extracted imaging data could be the product of the 
mechanisms occurring at a genetic and molecular 
level linked to the genotypic and phenotypic char-
acteristics of the tissue.4-7 Among its applications, 
radiomics has been evaluated to differentiate nor-
mal and pathological tissue.1-3,5 Hence, we thought 
about the potential use of radiomics in local re-
currence surveillance of soft tissue sarcoma. The 
incidence of local recurrence (LR) of STS is about 
6,5%–25% and is associated with poor outcome 
for patients.7 According to the American College 
of Radiology (ACR) Appropriateness Criteria 
guidelines, MRI is the most appropriate imaging 
test for LR surveillance of malignant or aggres-
sive musculoskeletal soft-tissue tumors.8 However, 
data informing the appropriate use of MRI in the 
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surveillance setting are conflicting.5,8,9 Indeed, 
MRI can differentiate local recurrence from post-
surgical seroma, hematoma, inflammation and 
scarring, but some post-operative changes in the 
surgical bed can be similar to those of recurrence 
with conventional T1-weighted, T2- weighted, and 
post-contrast sequences posing diagnostic dilem-
mas especially when sarcoma recurrence has low 
signal intensity on fluid-sensitive images.1,8-11 We 
hypothesized that radiomics analysis of MRI of pa-
tients undergoing follow-up for STS allows to dif-
ferentiate normal tissue from pathological tissue of 
LR. Therefore, the aim of our study was to perform 
a radiomics analysis of MRI of patients undergo-
ing local surveillance for Soft-tissue sarcoma recur-
rence. 
Patients and methods
This is an exploratory study of an ongoing Italian 
prospective (blind) multicenter study with insti-
tutional review board approval (blind). Written 
informed consent was obtained from participants. 
This study is endorsed by ESSR (European Society 
of Musculoskeletal Radiology). Prospective recruit-
ment of patients, as per protocol, includes MRI and 
US with commercially available equipment. MRI 
parameters of sequences included in the radiomics 
analysis are reported in Table 1.
Patients 
All consecutive MRI Images of follow-up events 
acquired between March 2016 to September 2018 
were included. A follow-up event was considered 
a complete MRI assessment to exclude STT LR. 
Inclusion criteria were: patients included were 18 
years and older operated on for localized soft tis-
sue sarcomas of the limb. Exclusion criteria were 
patients unable to understand or execute written 
informed consent, unable or unwilling to agree to 
follow-up during observation period and patients 
with metastatic disease. 
Experimental design
This study focused on finding if some radiomics 
features could discriminate on MRI patients who 
had confirmed significant disease at histology (LR) 
from those who did not. To ensure unbiased assess-
ment, all MRI annotations were performed blinded 
to the biopsy findings. Only cases with matched lo-
cations (surgery, biopsy, reports, and radiologist’s 
delineations) were considered for inclusion in this 
study.
Two data-sets were created: pathological and 
control. 
Each data set includes MRI images each with 
distinctive Regions of interest (ROIs). ROIs were 
positioned by two researchers (blind and blind; R1 
and R2 respectively) expert in quantitative image 
analysis (8 and 4 years of experience) blindly one 
from each other. R1 and R2 ROIs data were used 
separately for intra- and inter-observer agreement 
estimation while the mean value was used for 
other estimations. Discrepancies higher that 15% 
between R1 ROI and R2 ROI were handled with 
arbitration.     
Regions of interest including all the visible tu-
mor or suspicious area represented the pathologi-
cal data-set. Regions of interest in the same slices 
of tissue with no imaging evidence of recurrence 
according radiological assessment represented the 
control data-set. ROIs of control-data set were po-
sitioned not before 20 mm to the tumor to exclude 
inclusion of tumoral tissue. We did not include 
cancer cases with recurrences detected only with 
US. Image analysis was done per-lesion and not 
per-patient (Figure 1). 
Radiomics analysis
Radiomics analysis was performed on all MRI im-
ages included in pathological and control data-set 
within manually selected ROIs (Figure 1) as previ-
ously done for other 3D radiological techniques.2 
From each image, we extracted 104 image fea-
tures using an open-source software platform for 







Repetition time / echo time (TR/TE) 500/8
Acquisition voxel size (mm3) 0.6x0.7x3.0
T2-weighted MR imaging*
Repetition time / echo time (TR/TE) 6200/110
Acquisition voxel size (mm3) 0.6x0.7x3.0
T1-weighted MR imaging* with Gadolinium
Repetition time / echo time (TR/TE) 5/3
Acquisition voxel size (mm3) 0.6x0.7x3.0
*  T2-weighted MR imaging and T1- weighted MR imaging with Gadolinium 
are acquired with fat-saturation
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medical image informatics, image processing, and 
three-dimensional visualization (3D Slicer 4.7; 
www.slicer.org) built over two decades through 
support from the National Institutes of Health and 
a worldwide developer community. 3D-Slicer can 
be employed for quantitative image feature extrac-
tion and image data mining research in large pa-
tient cohorts.6 
Preprocessing
All patients were examined by using a 1.5-Tesla 
equipment (Magnetom Avanto, Siemens 
Heathcare) with a standard protocol. For each 
patient, T1-weighted (T1w), Gd-enhanced T1-
weighted (T1WGd) with 0.1-mmol/kg doses of 
gadoteric acid and T2-weighted with fat saturation 
(T2w fs) volume images were resampled to an uni-
form pixel spacing of 0.5 x 0.5 x 3mm. Then they 
were cropped to the lesion region of interest as de-
lineated by R1 and R2. Inhomogeneity correction 
was applied to T1w and T2w fat saturated images 
to account for the presence of bias field artifacts. 
Next, T1w and T2w fs images were corrected for 
inherent acquisition-to acquisition signal intensity 
variations (non standardness) using scale-based 
standardization. This procedure was applied to 
mitigate the inherent drift phenomenon that ac-
companies MRI intensities as previously done in 
literature.12
Statistical analysis
A) Comparison of radiomics features of normal 
and pathological tissue on MRI was done with non-
parametric tests (Mann-Whitney U test for unpaired 
data with 1000 bootstraps samples to compare pa-
tients and controls) considering a p value of 0.05 as 
statistically significant. B) Accuracy was measured 
using receiver operating characteristic (ROC) analy-
ses to estimate the area under the curve (AUC) and 
by estimating thresholds for sensitivity and specific-
ity for the radiomics features that significantly dif-
fered between patients and controls, considering the 
mean value, to avoid over-fitting. Ninety-five per-
cent confidence intervals (95%CIs) were calculated. 
Using statistical software, p values below 0.05 were 
considered statistically significant. C) Correlation 
analysis and univariate linear regression were per-
formed to determine the association between the ra-
diomics features and the corresponding clinical and 
prognostic parameters. Bonferroni correction was 
used to adjust for multiple comparisons. D) Mean 
time for single patient radiomics analysis was also 
calculated. Reading time was estimated with a com-
mercially available stopwatch including the time to 
download images, perform image adjustment and 
analysis and finally data collection in the database. 
Statistical tests were done using statistical software 
(STATA MP, StataCorp, 4905 Lakeway Dr, College 
Station, TX, USA and MedCalc). E) Intra-observer 
agreement was estimated: for research purposes 
Cronbach’s alpha was considered acceptable if be-
tween 0.7 and 0.8.13
Results
Intra-observer agreement resulted to be 0.62 (95% 
CI: 0.52–0.67) for single measurements and 0.75 
(95% CI: 0.69–0.80) for the average measure and 
was deemed acceptable for the purpose of the 
FIGURE 1. Example of workflow.
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study. There were no discrepancies higher that 
15% between R1 ROI and R2 ROI requesting arbi-
tration.    
N = 11 adult patients (6 men and 5 women) with 
suspicious STS LR were included for a total of 33 
follow-up events on MRI. A total of 198 data-sets 
per patients of both pathological and normal tissue 
were analyzed (99 pathological and 99 control da-
ta-sets). Characteristics of the 19 pathological find-
ings in 33 follow-up events are reported in Table 2. 
N = 3 patients had multiple lesions. 
After feature number reduction to avoid overfit-
ting, Mann-Whitney U test identified n = 7, n = 13 
and n = 12 features able to differentiate pathologi-
cal tissue from normal tissue on T1w MRI images, 
T2w fat saturated MRI images and T1wGd respec-
tively (p < 0.001). Table 3 shows feature domain ac-
cording to different MRI sequences.
Some radiomics features were significantly cor-
related to tumor size: 4 features (Compactness, 
MajorAxis, Flatness, Mean) with r = 0.75 with p < 
0.02, on T1w MRI images, 2 features (MajorAxis, 
RootMeanSquared) on T2w fat saturated MRI 
images with r = 0.65 with p < 0.01, and 2 features 
(MajorAxis, Maximum) on T1wGd with r = 0.65 
with p < 0.01. Four radiomics features (Sum en-
tropy, difference entropy, energy, lmc2) were cor-
related with grading (4 features with r = 0.74 and 
p < 0.05) on T1w MRI images and none on T2w fat 
saturated MRI images and T1wGd respectively. 
TABLE 2. Distribution of the extremity soft tissue sarcoma 
patients’ clinical characteristics in 19 pathological findings of 
11 patients in 33 follow-up events.  N = 3 patients had multiple 
lesions
Clinical Characteristic
Age (years)  57.8 ± 17.8










Upper extremity 5 (26)
Lower extremity 14 (74)
Histology (%)
Pleomorphic liposarcoma 6 (33)
Myxofibrosarcoma 5 (27)
Myxoid liposarcoma 2 (10)
Leiomyosarcoma 2 (10)
Nerve sheath tumors 2 (10)
Synovial sarcoma 2 (10)
TABLE 3. Feature domain according to different MRI sequences






Shape domain descriptors of the three-dimensional size and shape of the ROI. 
These features are independent 
from the gray level intensity 
distribution in the ROI and are 
therefore only calculated on the 
non-derived image and mask
1 1 2
First order
Mean, standard deviation, median, 
and range; first-order differentials 
computed using Sobel operators
Localize hypo- and hyperintense 
regions; gradients detect edges 





Localization of regions with 
significant intensity changes; 
gradients detect edges
and quantify region boundaries




Gray level run 
lenght matrix 
(glrlm)
quantifies gray level runs, which are 
defined as the length in number 
of pixels, of consecutive pixels that 
have the same gray level value.
In a gray level run length matrix 
the element describes the 
number of runs with gray level 
and length occur in the image 
(ROI) along angle
2 3 6
Gray level size 
zone matrix (glszm) 
domain
It is an advanced statistical matrix 
used for texture characterization. 
It estimates bivariate conditional 
probability density function of the 
image distribution values
represent the count of how 
many times a given size of given 
grey level occur
0 0 0
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ROC analysis performed on T1w images, T2w 
fat saturated images and T1wGd showed an AUC 
between 0.71 (95%CI: 0.55–0.87) and 0.96 (95%CI: 
0.87–1.00). Detailed results are reported in Table 4 
and Figure 2. T2w fat saturated with fat-saturation 
and T1w post-Gadolinium showed a better perfor-
mance than T1w images (p < 0.05).
Mean time to perform radiomics analysis was at 
least 5 h per patient including the creation of a data 
set of 19 patients with suspicious cancer visible at 
MRI, therefore the total time to perform analysis, 
excluding the time to recruit and select patients 
was at least 100 h.
Discussion
In this study we performed a radiomics analysis on 
MRI images of patients suspected of having STS LR 
belonging to an ongoing prospective trial. The aim 
was to investigate whether radiomics features de-
rived from standard clinical MRI sequences could 
be used to differentiate normal tissue from cancer-
ous tissue of LR. In clinical practice, differentiating 
normal from pathological tissue on MRI in patients 
suspected of having LR is relevant especially when 
LR are not nodules, but plaque-like “tails” of tu-
mor on MRI, especially for both undifferentiated 
pleomorphic sarcoma and myxofibrosarcoma.5,11 
Despite the relatively low number of patients in-
cluded in this study, we had a high percentage of 
pleomorphic sarcoma/liposarcoma and/or myxo-
fibrosarcoma accounting for 11/19 of the lesions 
evaluated. The number of lesions evaluated in this 
study is similar to the number of pleomorphic sar-
coma/liposarcoma and/or myxofibrosarcoma eva-
luted in the study by Corino et al.14 In the study by 
Corino et al.14, a radiomics approach with first order 
features performed on 13 pleomorphic sarcoma/li-
posarcoma and/or myxofibrosarcoma resulted in 
good accuracy and AUC. In the present study, the 
number of pleomorphic sarcoma/liposarcoma and/
or myxofibrosarcomas evaluated could be consid-
ered relatively high considering that patients un-
derwent MRI evaluation for LR and not of a pri-
mary tumor. MRI could be challenging in these 
patients and the use of radiomics could enhance 
the role of MRI in STS local surveillance. Chou et al. 
15 reported MRI sensitivity for LR detection rang-
ing from 69%without contrast medium to 90% with 
contrast-enhanced sequences. AUCs of this study, 
especially for T1w post-gadolinium and T2w fat 
saturated are better that 90%. As reported by Fayad 
L. et al.16, postoperative inflammation and fibrosis 
in the surgical bed may share many of the same 
characteristics as tumor on conventional MR imag-
es. Indeed they can occasionally appear mass-like. 
Only in the absence of abnormal T2-weighted sig-
nal intensity the presence of recurrent tumor could 
be excluded. Very rarely, a sarcoma recurrence 
FIGURE 2. Examples of AUCs with a reduced number of features on T1w, T2w fat saturated with fat-saturation, and T1w post-Gadolinium showing a better 
performance for T2w fat saturated with fat-saturation and T1w post-Gadolinium (p < 0.05). Features from 1 to 26 belong to the shape domain; features 
(VAR00..) from 27 to 45 belong to the first order domain; features from 46 to 72 belong to the glcm (gray-level co-occurrence matrix) domain; features 
from 73 to 88 belong to gray level Run Lenght Matrix (glrlm) domain; features from 88 to 104 belong to the gray level size zone matrix (glszm) domain.
TABLE 4. ROC results according to different MRI sequences of the selected features.* 
T2-weighted MR imaging and T1-weighted MR imaging with Gadolinium are 
acquired with fat-saturation. Areas under the curve for differentiation of normal and 
pathological tissue (LR) had p < 0.05
Sequence Minimum AUC 95%CI
Maximum 
AUC 95%CI
T1-weighted MR imaging 0.71 0.54–0.88 0.84 0.77–0.96
T2-weighted MR imaging* 0.81 0.67–0.95 0.91 0.83–1.00
T1-weighted MR imaging* 
with Gadolinium 0.87 0.69–1.00 0.96 0.87–1.00
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may be of low signal intensity on T2-weighted 
images and a T1-weighted study shows architec-
tural distortions due to the tumoral presence. We 
believe that in these difficult radiological cases, ra-
diomics may help even expert Radiologists in the 
detection of LR. A preliminary report showed that 
using a radiomics approach to characterize mus-
culoskeletal tumors, machine learning performs 
even better than expert radiologists17 (Chhabra A, 
personal communication). Indeed, the main result 
of this study is that few radiomics features can dif-
ferentiate LR from normal tissue on T1w MRI im-
ages, T2w fat saturated MRI images and T1w post-
gadolinium sequences. These features belonged to 
different classes. The majority of them belonged to 
the gray level co-occurrence matrix (GLCM) do-
main possibly reflecting underlying heterogeneity 
of voxel intensities. Although it is known that in 
soft-tissue tumors fluid-sensitive images should 
have a more favorable contrast between tumor and 
surrounding because skeletal muscle is of interme-
diate signal intensity, radiomics features were able 
to differentiate LR from normal tissues even on 
T1w sequences. This data reflects the great value of 
this application for STT survelliance. In addition, 
a very good AUC can be obtained with only few 
features for every MRI sequence. We acknowledge 
that, according to standard clinical practice, T2w 
fat saturated and post-contrast T1w sequences had 
the best AUCs. After feature reduction to avoid de-
crease the performance18 we found that a set of few 
radiomics features had an AUC generally better 
than data reported for conventional MRI. Indeed, 
radiomics based AUC for T1-weighted MR imag-
ing with Gadolinium reached a best result of 0.96. 
These data support the design of future studies 
using of radiomics for STS surveillance. In addi-
tion, in spite of the small number of patients, some 
radiomics features correlated with tumor size and 
grading. These data support the hypothesis that 
few radiomics features could reflect tumoral biol-
ogy and aggressiveness.14 We acknowledge that 
mean time to perform radiomics analysis was long 
and intra-observer agreement resulted acceptable 
for the purpose of the study. In addition, a dif-
ferent selection of the ROI could lead to a differ-
ent measurement of the features even with good 
intra- and inter-observer agreement. Further im-
provements are needed to accelerate the workflow 
in clinical practice and to keep ROIs as stable as 
possible although we did not have any cases with 
discrepancies higher that 15%. 
This study has several limitations. First, radi-
omics features were not extracted on ADC maps, 
that have been demonstrated to assess tumor cel-
lularity even when different scanners are used.14 
However, this is not a multicentric study and the 
MRI image sample was included from only one 
center. Second, the study population was relatively 
small. However, considering the incidence of LR in 
patients who underwent surgery for STT (reported 
rates of LR range from 6.5% to approximately 25%)5, 
the number of patients and images evaluated seem 
to be sufficient for the purpose of the study. The 
presence of a relatively high number of pleomor-
phic sarcoma and myxofibrosarcoma increases the 
clinical significance of the study because they are 
tumors difficult to be evaluated on MRI. Selection 
biases are excluded due to consecutive patient 
enrollment in the present study. Moreover, three 
MRI sequences per lesion were analyzed increas-
ing data robustness. Finally, we also acknowledge 
that future software developments will reduce the 
necessity of freehand ROIs positioning.19 We also 
believe that further research will be critical to fully 
unveil the potential or radiomics in STT evaluation, 
indeed, it has been studied that radiomics features 
extracted from MR images are independently asso-
ciated with survival when accounting for age and 
tumor grade and helps in differential diagnosis.20,21
In conclusion, radiomics features allow to de-
tect LR on MRI images in STS local surveillance. 
radiomics in STS evaluation is useful not only for 
detection purposes but also for lesion biological 
characterization.
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